Trives Folguera, LauraMuñoz Fernández, SantiagoEsteban Ortega, María del MarCobo Ibáñez, María TatianaVergara Dangond, CristinaRomero Bogado, LizCámara Fernández, Isabel de laRichi Alberti, PatriciaBeatriz Paredes, MaríaEsteban Vázquez, AnaThuissard Vasallo, Israel JohnSteiner, MartinaEt. al.2026-02-172026-02-172025Trives-Folguera, L., Muñoz-Fernández, S., Esteban-Ortega, M. D. M., Coca-Serrano, R., Cobo-Ibañez, T., Vergara-Dangond, C., Romero-Bogado, L., De La Cámara-Fernández, I., Richi, P., Paredes, M. B., Esteban-Vazquez, A., Acosta, A. V., Najera, G. C., José, M. A. S., González-Martín, J. J., Franco Gomez, K. N., Bogas Schay, P., Shukair Harb, T., Thuissard-Vasallo, I., & Steiner, M. (2025). Choroidal thickness as a biomarker of systemic inflammation in patients with polymyalgia rheumatica. Frontiers in Medicine, 12, 1689327. https://doi.org/10.3389/fmed.2025.16893272296-858Xhttps://hdl.handle.net/11268/16827Choroidal thickness (CT) varies with systemic inflammatory activity in diseases such as spondyloarthritis, suggesting its potential role as a biomarker. This study aimes to evaluate changes in CT in patients recently diagnosed with Polymyalgia Rheumatica (PMR) who are undergoing corticosteroid therapy, over a six-month follow-up period. This is a prospective, observational, longitudinal pilot study including 20 patients with recent PMR diagnosis from two centres.engAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/Polimialgia reumáticaBiomarcadoresTomografía de coherencia ópticajournal article10.3389/fmed.2025.1689327open accessInvestigación médicaMedicina preventivaLucha contra las enfermedadesGoal 3: Ensure healthy lives and promote well-being for all at all ages